Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.

about

New Kids on the Block: RNA-Based Influenza Virus Vaccines.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus New Vaccine Technologies to Combat Outbreak Situations

P2860

Q52609655-E3BC3741-939C-4421-907D-777793E39B99 Q56535662-ED282AEF-6436-4278-89C3-D8C3749A8038 Q57072744-D838DCB6-4264-4BBA-AC2C-9B79D6A7860E

P2860

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.

Item

http://www.wikidata.org/entity/Q47243721

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@en

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@nl

type

Item

label

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@en

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@nl

altLabel

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease

@en

prefLabel

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@en

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@nl

P1476

Modified mRNA-Based Vaccines E ...... Pigs From Ebola Virus Disease.

@en

P2093

Alexander Bukreyev

http://www.w3.org/2001/XMLSchema#string

Eric Huang

http://www.w3.org/2001/XMLSchema#string

Giuseppe Ciaramella

http://www.w3.org/2001/XMLSchema#string

Michelle Meyer

http://www.w3.org/2001/XMLSchema#string

Olga Yuzhakov

http://www.w3.org/2001/XMLSchema#string

P2860

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.

mRNA-based therapeutics--developing a new class of drugs.

P304

451-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIX592

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

217

http://www.w3.org/2001/XMLSchema#string

P50

Palani Ramanathan

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29281112

http://www.w3.org/2001/XMLSchema#string

P921

Ebola virus

P932

5853918

http://www.w3.org/2001/XMLSchema#string

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.

about

P2860

P2860

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932